Lidocaine Hydrochloride Injection, Solution
Product Images NDC 72603-722

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Lidocaine Hydrochloride (NDC 72603-722). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northstar Rxllc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lidocaine1percent20mlcarton (Lidocaine1percent20mlcarton)

Carton label for Lidocaine HCl Injection, USP 1% (200 mg/20 mL or 10 mg/mL) multiple-dose vials, 25 x 20 mL. The label shows red and blue color bands with product name, strength, dosage form, and usage instructions specifying infiltration and nerve block, not for caudal or epidural use. Manufactured for NorthStar Rx LLC and Aspin Pharma Limited, with NDC 72603-722-25.*

FDA Label Image

Lidocaine1percent20mlvial (Lidocaine1percent20mlvial)

Label for Lidocaine HCl Injection, USP 1% (200 mg/20 mL, 10 mg/mL) sterile solution in a 20 mL multiple-dose vial. Indicated for infiltration and nerve block, not for caudal or epidural use. Manufactured for NorthStar Rx LLC by Aspiro Pharma Limited, India. Storage instructions included.*

FDA Label Image

Lidocaine1percent50mlcarton (Lidocaine1percent50mlcarton)

Packaging label for Lidocaine HCl Injection, USP 1% solution at 10 mg/mL strength. The label indicates the product is for infiltration and nerve block, not for caudal or epidural use, sterile and nonpyrogenic. It comes in multiple-dose 50 mL vials, with 25 vials per package. The labeler is NorthStar Rx LLC, and manufacturing details and storage instructions are included.*

FDA Label Image

Lidocaine1percent50mlvial (Lidocaine1percent50mlvial)

Label for Lidocaine HCl Injection, USP 1% (10 mg/mL) in a 50 mL multiple-dose vial. The label states the product is for infiltration and nerve block use but not for caudal or epidural use. It is sterile, nonpyrogenic, and can be resterilized by autoclaving. The labeler is NorthStar Rx LLC, with manufacturing by Aspiro Pharma Limited, India. Storage instructions specify 20° to 25°C (68° to 77°F).*

FDA Label Image

Lidocaine2percent20mlcarton (Lidocaine2percent20mlcarton)

Packaging label for Lidocaine HCl Injection, USP 2% (20 mg/mL) solution for infiltration and nerve block. The label indicates 25 vials of 20 mL multi-dose vials. The product is labeled as sterile and nonpyrogenic, manufactured by Aspiro Pharma Limited for NorthStar Rx LLC. The label includes storage conditions and ingredients information.*

FDA Label Image

Lidocaine2percent20mllabel (Lidocaine2percent20mllabel)

Label for Lidocaine HCl Injection, USP 2% (400 mg/20 mL, 20 mg/mL) multiple-dose vial by NorthStar Rx LLC. The drug is indicated for infiltration and nerve block, not for caudal or epidural use. Label includes storage instructions, lot and expiry placeholders, barcode, and manufacturing information for Aspiro Pharma Limited, India.*

FDA Label Image

Lidocaine2percent50mlcarton (Lidocaine2percent50mlcarton)

Packaging label for Lidocaine HCl Injection, USP 2% (1000 mg/50 mL or 20 mg/mL) solution. The label indicates use for infiltration and nerve block, not for caudal or epidural use. It contains 10 multi-dose vials of 50 mL each. Manufactured for Northstar Rx LLC, Memphis, TN, by Aspiro Pharma Limited, India. The label also lists inactive ingredients and storage instructions.*

FDA Label Image

Idocaine2percent50mllabel (Lidocaine2percent50mllabel)

Label for Lidocaine HCl Injection, USP 2% (1000 mg/50 mL, 20 mg/mL) in a 50 mL multiple-dose vial. For infiltration and nerve block, not for caudal or epidural use. Manufactured for Northstar Rx LLC, Memphis, TN by Aspiro Pharma Limited, India. Label includes storage instructions and warnings about solution integrity.*

FDA Label Image

Lidocainestructure (Lidocainestructure)

Chemical structure of lidocaine hydrochloride. The structure depicts the molecular arrangement of atoms in lidocaine, including aromatic rings, amide groups, and ethyl substituents, along with the hydrochloride component.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.